Articles On Sigma Healthcare (ASX:SIG)

South32 Ltd (ASX: S32) shares have rushed to 52-week highs in the past month. In the past 6 months, the share price has soared by 58% to $4.62 at the time of writing. In 2025, South32 shares experienced a rough patch that saw the mining...

ASX health sector up 0.11% for the week, while broader market rises 0.23% Week dominated by quarterly results with several companies reaching key milestones  Morgans upgrades Imricor after  US FDA breakthrough clearance for its NorthStar M...

When it comes to finding Australian stocks to buy, I'm more interested in long-term compounding than short-term trades. Two stocks that I think fit the bill for long-term investments are discussed in this article. Here's why I'd feel com...

I am an investor who tries to invest what I can and when I can into the markets. There are precious few certainties in the world of investing. But two of them are that the markets go up far more often than they go down in a stock market cra...

S&P/ASX 200 Index (ASX: XJO) shares closed higher on Tuesday, up 0.92% to 8,941.6 points. In this article, three experts provide their views on three big names in the marketplace today. South32 Ltd (ASX: S32) The South32 sh...

Share prices and earnings are always changing and this gives investors the opportunity to buy an undervalued ASX share. It can be particularly attractive to invest in growing businesses because rising profits are a natural tailwind for c...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Buoyed by buying in big tech, the Nasdaq led US markets higher overnight, albeit fin...

With February reporting season fast approaching, investors face a familiar decision. Do you wait for results and risk paying a higher price, or do you act early and accept the uncertainty that comes with buying ahead of updates? If I we...

The large listed investment company (LIC) Australian Foundation Investment Co Ltd (ASX: AFI) released its FY26 half-year result yesterday, revealing a number of interesting S&P/ASX 200 Index (ASX: XJO) share investment choices it thinks...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin President Trump's de-escalation of geo-political tensions at Davos underpinned a vol...

The Australian Foundation Investment Co Ltd (ASX: AFI) share price is in focus today after posting a half-year profit after tax of $147.0 million, down 4.6% compared to the same time last year. Revenue from operating activities dipped 2.8%...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin The collision of rising Japanese bond yields and geopolitical tensions between the U...

When people talk about ASX growth shares, the focus often falls on the same familiar names.  That makes sense. Quality businesses tend to attract attention. But it also means some companies with genuine earnings potential get overlooked,...

If I were looking to make some additions to my investment portfolio this week, I would seriously consider the five ASX 200 shares in this article. Not only could they be good value at current prices, but I think they have the potential t...

Healthcare was the worst performer of the 11 market sectors in 2025, with the S&P/ASX 200 Healthcare Index (ASX: XHJ) falling 24.91%. The typically small dividend paid by healthcare shares offset this only slightly, with the sector's...

These 3 ASX healthcare shares have all had their fair share of issues over the past few months. Investors walked out, and as a result the share prices of CSL Ltd (ASX: CSL), Sigma Healthcare Ltd (ASX:SIG) and Sonic Healthcare Ltd have be...

When I think about which stocks I want to own through 2026 and beyond, I'm not looking for the next hot trade or a quick bounce. I'm looking for businesses that can compound steadily, navigate uncertainty, and still look relevant several ye...

Not everyone can afford to invest tens of thousands of dollars into ASX shares. But that doesn't matter because you don't need to do that to build wealth in the share market. In reality, consistency often matters far more than the size...

In 2026, I'm focused on owning businesses with clear competitive advantages, sensible balance sheets, and management teams that have proven they can execute. They are ASX stocks I would be comfortable holding through market volatility,...

As 2026 gets underway, I'm looking for ASX stocks that I believe can continue to grow, adapt, and compound value over time. With that in mind, these are five stocks I'm particularly eager to buy for my portfolio in 2026. DroneShield...

At the beginning of a new year, I like to narrow my focus rather than expand it. Instead of looking at dozens of ASX stocks, I concentrate on a small group of businesses I would genuinely be happy to own for the long term. These are com...

As we look ahead to 2026, I'm less focused on predicting short-term market moves and more interested in owning businesses that can continue to compound value over time. The ASX 200 is home to many of Australia's highest-quality companies...

Owning Sigma Healthcare Ltd (ASX: SIG) shares could be a pleasing choice for long-term dividend income. It may not have a reputation for being an ASX dividend share year, but if it's able to deliver year after year growth, then it could...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin The Nasdaq rallied as Tesla shares hit a new all time high while oil prices continue...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Technology stocks led by Oracle and Broadcom continued to weigh on the Nasdaq overni...

Highlights Broad market pressure weighs on Australian equities Commodity weakness shapes mining sentiment Defensive and selective sectors show resilience Australian equities opened the week under pressure as commodity...

In a pre-Christmas rush, biotechs report a flurry of clinical activity Radiopharm shares surge up to 22% on strong brain-imaging results Morgans says Sigma Health and EBOS Group shares are just the prescription for the Christmas hamper  ...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Led by a sell off in Broadcom and Oracle, the Nasdaq led US markets lower on Friday...

The team at Macquarie just released its latest High Frequency Consumer Data report and consumer stock picks.  This included stock picks from both consumer discretionary and staples sectors.  Its High Frequency Consumer Data series pro...

It was a tough Tuesday for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares today. After a bouncy day, the ASX 200 ended up closing 0.45% lower, probably unassisted by the Reserve Bank of Australia'...

The Sigma Healthcare Ltd (ASX: SIG) share is slowly slipping toward this year's record low of $2.74. Monday it lost another 2% to close at $2.79. In 2025, the $33 billion dollar pharmacy group has lost 5.2% in value and in the past 6 mon...

The L1 Long Short Fund Ltd (ASX: LSF) is one of the most successful ASX stocks on the Australian share market. Since duplicating its managed fund into a listed investment company (LIC) back in 2018, this LIC's portfolio has generated an ave...

Highlights Clear snapshot of major uptrends and downtrends across sectors Quick context on why scan lists matter for market monitoring Thematic takeaways across resources, property, healthcare and tech Today’s trend sc...

Good Afternoon and welcome to the start of Week 49 I’m Jon Davidson. I’d say here’s to a happy December, but you might be among shareholders caught up in today’s ASX announcements outage, the latest bungle to come from the bourse operator,...

Two leading investment experts say that now is the time to sell these three S&P/ASX 200 Index (ASX: XJO) stocks. One of the companies is a fast food operator, the second is an Aussie rare earths miner, and the third is an Australian ret...

Owning Sigma Healthcare Ltd (ASX: SIG) shares means gaining exposure to several healthcare businesses, including Chemist Warehouse. After dropping 7% since the November peak, I think it's worth asking whether the business is a buy-the-dip o...

The CSL Ltd (ASX: CSL) share price decline of 35% this year (at the time of writing) is one of the biggest among ASX blue-chip shares in 2025. While the company has decades of delivering growth under its belt, the market now seems mo...

One of the many positives of ASX ETFs is the ability to gain exposure to niche themes or sectors.  A trend that is becoming increasingly prevalent is the focus on ESG investing. ESG investing is based on environmental, social, and gov...

When markets get choppy, many investors sit on the sidelines waiting for conditions to get better. But long-term wealth is built by doing the opposite, buying high-quality stocks when uncertainty drags their share prices lower. Right now, t...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) fought hard and recorded a small gain. The benchmark index rose 0.15% to 8,537 points. Will the market be able to build on this on Wednesday? Here are five things to watch: ASX 200 expected...

Shares in the S&P/ASX 200 Index (ASX: XJO) biotech stock CSL Ltd (ASX: CSL) closed yesterday trading for $182.14. CSL shares remain down a sharp 35.32% in 2025. Taking a tiny bit of the sting out of those losses, the ASX 200 stock also...

Felix Gold Ltd (ASX: FXG) has become one of the ASX's standout performers over the past twelve months. Shares in this mineral explorer have ballooned by nearly 500% in just one year, climbing to $0.41 per share at the time of writing....

If you have space in your portfolio for some new additions, it could be worth hearing what analysts are saying about the ASX shares in this article, courtesy of The Bull. Let's see if they are buys, holds, or sells right now: CSL Ltd (ASX:...

With 2026 fast approaching, we look at three S&P/ASX 200 Index (ASX: XJO) titans leading analysts expect to outperform in the months ahead. One of the promising companies operates in the global defence space, while the other two are in...

CSL Ltd (ASX: CSL) shares are marching higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) biotech stock closed yesterday trading for $180.08. In morning trade on Wednesday, shares are changing hands for $181.73 apiece, up 0.9%%....

Sonic Healthcare Ltd (ASX: SHL) has hit its lowest share price in years. On Tuesday the prominent ASX 200 share closed lower on $20.89, which brings the loss this year to 23%. Sonic Healthcare is a global diagnostics and pathology powerh...

CSL Ltd (ASX: CSL) shares have been in the spotlight in recent weeks. Following the release of a disappointing trading update, the biotechnology giant's shares have tumbled into the red again. Is this a buying opportunity? Let's see what an...

ASX 200 healthcare shares are among just two market sectors in the green today, with the other nine all in the red. The S&P/ASX 200 Health Care Index (ASX: XHJ) is up 0.085% compared to a 1% decline for the S&P/ASX 200 Index (A...

Time and again we've seen how leading S&P/ASX 200 Index (ASX: XJO) blue-chip shares are capable of delivering strong profits and returns for shareholders. There's usually a reason why that business has risen to the top of the pile an...